Gland Pharma Limited (GLAND.NS)

INR 1764.95

(0.06%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 106.61 Billion 87.77 Billion 78.33 Billion 64.96 Billion 40.86 Billion 35.23 Billion
Total Current Assets 56.45 Billion 69 Billion 58.52 Billion 51.23 Billion 28.46 Billion 23.57 Billion
Cash And Short Term Investments 18.39 Billion 38.36 Billion 32.42 Billion 24.46 Billion 13.12 Billion 7.2 Billion
Cash and Cash Equivalents 18.39 Billion 19.08 Billion 3.15 Billion 4.91 Billion 1.69 Billion 2.36 Billion
Short Term Investments 17.34 Billion 19.27 Billion 29.26 Billion 19.54 Billion 11.42 Billion 4.84 Billion
Net Receivables 15.58 Billion 8.71 Billion 12.51 Billion 12.72 Billion 7.76 Billion 5.52 Billion
Inventory 16.55 Billion 19.45 Billion 11.85 Billion 12.75 Billion 7.56 Billion 9.11 Billion
Other Current Assets 5.91 Billion 2.47 Billion 1.72 Billion 1.29 Billion 10.54 Million 7.24 Billion
Total Non-Current Assets 50.16 Billion 18.76 Billion 19.81 Billion 13.72 Billion 12.39 Billion 11.66 Billion
Net PPE 38.3 Billion 17.36 Billion 17.26 Billion 13.24 Billion 11.96 Billion 10.95 Billion
Good Will And Intangible Assets 3.54 Billion 116.61 Million 125.35 Million - - -
Good Will 2.42 Billion - - - - -
Intangible Assets 1.12 Billion 116.61 Million 125.35 Million - - -
Long-Term Investments 6.55 Billion -733.66 Million 2 Billion -19.47 Billion 16.61 Million 13.28 Million
Tax Assets 504.37 Million 958.88 Million -415.05 Million - - -
Other Non Current Assets 1.25 Billion 1.06 Billion 836.15 Million 19.95 Billion 411.86 Million 697.39 Million
Other Assets - - - - - -
Total Liabilities 19.37 Billion 8.18 Billion 6.76 Billion 5.92 Billion 4.39 Billion 6.61 Billion
Total Current Liabilities 13.98 Billion 7.29 Billion 5.82 Billion 5.12 Billion 3.59 Billion 5.32 Billion
Account Payables 8.62 Billion 5.87 Billion 4.62 Billion 4 Billion 2.49 Billion 4.46 Billion
Tax Payables 516.37 Million 9.85 Million 179.79 Million 286.9 Million 107.23 Million 110.04 Million
Short Term Debt 2.3 Billion 7.09 Million 2.61 Million 2.97 Million 10.17 Million 6.2 Million
Deferred Revenue 516.37 Million 486.08 Million 636.57 Million 1.05 Billion 917.95 Million 741.64 Million
Other Current Liabilities 2.53 Billion 924.66 Million 552.57 Million 63.25 Million 171.17 Million 117.87 Million
Total Non Current Liabilities 5.39 Billion 896.8 Million 939.75 Million 803.12 Million 807.81 Million 1.28 Billion
Long-Term Debt 1.06 Billion 37.44 Million 44.82 Million 46.98 Million 49.94 Million 60.11 Million
Deferred Revenue Non Current 346.79 Million 49.94 Million 55.54 Million 56.67 Million 58.02 Million 201.61 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.77 Billion -32.61 Million -38.21 Million -39.34 Million -40.69 Million -49.6 Million
Other Liabilities - - - - - -
Total Equity 87.23 Billion 79.58 Billion 71.57 Billion 59.03 Billion 36.46 Billion 28.61 Billion
Stock Holders Equity 87.23 Billion 79.58 Billion 71.57 Billion 59.03 Billion 36.46 Billion 28.61 Billion
Common Stock 164.71 Million 164.7 Million 164.3 Million 163.59 Million 154.95 Million 154.95 Million
Retained Earnings 67.87 Billion 60.15 Billion 52.34 Billion 40.22 Billion 30.25 Billion 22.52 Billion
Accumulated other comprehensive income 87.07 Billion -15.59 Million 114.54 Million 240.93 Million 160.28 Million 47.64 Million
Common Stock Equity 87.23 Billion 79.58 Billion 71.57 Billion 59.03 Billion 36.46 Billion 28.61 Billion
Capital Lease Obligation 346.79 Million 6.32 Million 8.1 Million 9.26 Million 10.51 Million 11.41 Million
Total Investments 6.55 Billion 18.53 Billion 2 Billion 69.52 Million 11.42 Billion 4.84 Billion
Total Debt 3.72 Billion 44.53 Million 47.43 Million 49.95 Million 60.11 Million 66.31 Million
Net Debt -14.67 Billion -19.04 Billion -3.11 Billion -4.86 Billion -1.63 Billion -2.29 Billion

Balance Sheet Charts